M. Sasaki et al., EFFECT OF LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, ON RESPONSE OF CORTISOL AND ALDOSTERONE TO ADRENOCORTICOTROPIC HORMONE, Journal of clinical pharmacology, 35(8), 1995, pp. 776-779
Many imidazole derivatives are shown to inhibit adrenal steroid biosyn
thesis. The present study was undertaken to examine an effect of anoth
er imidazole derivative, losartan (an angiotensin II receptor antagoni
st), on responses of cortisol and aldosrerone to adrenocorticotrophic
hormone (ACTH). Nine patients with essential hypertension were given p
lacebo orally for 7 days and 50 mg of losartan for the next 9 days. Re
sponses of serum cortisol and plasma aldosterone to intramuscular ACTH
injection were determined before and at the end of the treatment with
losartan. Serum cortisol and plasma aldosterone significantly increas
ed after ACTH injection in both periods of treatment (placebo and losa
rtan). The increments in these parameters during treatment with losart
an were not significantly different from those during treatment with p
lacebo. These results suggest that the inhibitory effect of losartan o
n adrenal steroid biosynthesis is negligible.